Articles related to KIDNEY DISEASE

These medications can reduce blood flow through the kidneys, which can contribute to kidney damage or failure. Patients with heart failure, liver disease, or existing kidney problems are at a higher risk.

“This guideline is a tour de force, not just a technical manual. It’s a roadmap for precision, prevention, and equity in hypertension care.” – Ragavendra Baliga, MBBS

Similar efficacy was observed in pediatric patients aged 12 years and older – demonstrating consistent treatment benefit across age groups in the pivotal trial.

Nationwide analysis of more than 75,000 patients reveals consistent CKD risk elevation across all age groups and genders, with strongest associations in patients requiring frequent clinical interventions.

Approximately 8% of adults use supplements potentially harmful to kidney function, with usage rates consistent regardless of CKD status, suggesting a critical need for targeted screening and counseling.

Post-trial analysis reveals a 13% relative reduction in cardiovascular death and kidney disease progression risk, though this benefit primarily manifests in the first 12 months after treatment discontinuation.